SSB
BIO icon

Sandy Spring Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sandy Spring Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-150
Closed -$63.1K – 1171
2022
Q4 		$63.1K Hold
150
– – ﹤0.01% 491
2022
Q3 		$63K Hold
150
– – ﹤0.01% 474
2022
Q2 		$74K Hold
150
– – ﹤0.01% 453
2022
Q1 		$84K Hold
150
– – ﹤0.01% 445
2021
Q4 		$113K Hold
150
– – 0.01% 420
2021
Q3 		$112K Hold
150
– – 0.01% 403
2021
Q2 		$97K Buy
+150
New +$91.3K 0.01% 436

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sandy Spring Bank's BIO Position: Q1 2023 in Review

Sandy Spring Bank sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2023, closing a stake of 150 shares — an estimated $63.1K sold.

Sandy Spring Bank first reported a position in BIO in Q2 2021 and held it in 7 quarters. The position peaked at $113K in Q4 2021. 504 funds tracked by Wall St. Rank hold BIO as of Q1 2023.

  • Sandy Spring Bank reported no remaining Bio-Rad Laboratories Class A position as of Q1 2023 after selling out during the quarter.
  • Sandy Spring Bank sold 150 Bio-Rad Laboratories Class A shares in Q1 2023, an estimated $63.1K.
  • Sandy Spring Bank first reported a position in Bio-Rad Laboratories Class A in Q2 2021 and held it in 7 quarters.
  • Sandy Spring Bank's Bio-Rad Laboratories Class A position peaked at $113K in Q4 2021.
  • 504 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2023.

Based on Sandy Spring Bank's 13F filing for Q1 2023, filed 5 May 2023.